Nanobac Pharmaceuticals Incorporated (NNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Sales | -3 | 6 | 2 | 5 | 10 |
| Cost of Goods | 0 | 5 | 1 | 4 | 10 |
| Gross Profit | 0 | 1 | 1 | 1 | 10 |
| Operating Expenses | 1,170 | 525 | 671 | 2,544 | 1,880 |
| Operating Income | -1,173 | -519 | -669 | -2,539 | -1,870 |
| Interest Expense | 60 | 40 | 40 | 40 | 70 |
| Other Income | 53 | -271 | -1 | -1,271 | 60 |
| Pre-tax Income | -1,180 | -830 | -710 | -3,850 | -1,880 |
| Net Income Continuous | -1,180 | -830 | -710 | -3,850 | -1,880 |
| Net Income | $-1,180 | $-830 | $-710 | $-3,850 | $-1,880 |
| EBITDA(a) | $-1,053 | $-409 | $-549 | $-2,429 | $-1,750 |